Skip to main content
. 2019 May 1;14(5):e0215952. doi: 10.1371/journal.pone.0215952

Fig 2. Experiment 2.

Fig 2

Glibenclamide did not reduce (A) brain water content (P = 0.629, group main effect) or (B) neurological deficits (P = 0.743). (C) Blood glucose was not impacted by glibenclamide (P = 0.531, group main effect). Sample size was n = 16/group.